Home ›
Trademark Categories ›
Pharmaceuticals ›
2020 ›
AD ›
ADAGIO THERAPEUTICS
Trademark search for:
ADAGIO THERAPEUTICS
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-08-14 — Application filed
2020-08-18 — Application filed
2020-09-17 — Application filed
2020-12-09 — Assigned to examiner
2020-12-13 — Final disposition recorded
2020-12-13 — Final disposition recorded
2020-12-13 — Final disposition recorded
2021-01-21 — Office action issued
2021-01-21 — Correspondence received in law office
2021-01-22 — Teas/email correspondence entered
2021-01-28 — Examiners amendment -written
2021-01-28 — Suspension letter written
2021-01-28 — Letter of suspension e-mailed
2021-01-28 — Notification of letter of suspension e-mailed
2021-01-28 — Examiners amendment e-mailed
2021-01-28 — Notification of examiners amendment e-mailed
2021-01-28 — Examiner's amendment entered
2021-06-29 — Teas response to suspension inquiry received
2021-07-20 — Assigned to lie
2021-07-21 — Teas/email correspondence entered
2021-07-21 — Correspondence received in law office
2021-08-20 — Final disposition recorded
2021-08-20 — Final disposition recorded
2021-08-20 — Final disposition recorded
2022-01-20 — Attorney/dom.rep.revoked and/or appointed
2022-01-20 — Teas change of correspondence received
2022-01-20 — Teas revoke/app/change addr of atty/dom rep received
2022-02-16 — Teas change of owner address received
2022-02-16 — Teas change of correspondence received
2022-02-16 — Applicant/correspondence changes (non-responsive) entered
2022-02-22 — Office action issued
2022-02-22 — Correspondence received in law office
2022-02-23 — Teas/email correspondence entered
2022-03-23 — Notice of unresponsive amendment - e-mailed
2022-03-23 — Notification of notice of unresponsive amendment - e-mailed
2022-03-23 — Report unresponsive amendment - completed
2022-04-07 — Examiners amendment -written
2022-04-07 — Approved for pub - principal register
2022-04-07 — Examiners amendment e-mailed
2022-04-07 — Notification of examiners amendment e-mailed
2022-04-07 — Examiner's amendment entered
2022-04-20 — Notification of notice of publication e-mailed
2022-05-10 — Published for opposition
2022-05-10 — Official gazette publication confirmation e-mailed
2022-07-05 — Noa e-mailed - sou required from applicant
2023-01-04 — Sou teas extension received
2023-01-04 — Sou extension 1 filed
2023-01-04 — Sou extension 1 granted
2023-01-06 — Notice of approval of extension request e-mailed
2023-07-24 — Attorney/dom.rep.revoked and/or appointed
2023-07-24 — Teas change of correspondence received
2023-07-24 — Teas revoke/app/change addr of atty/dom rep received
2023-08-07 — Application abandoned
2023-08-07 — Application abandoned
2023-08-07 — Final status recorded
Owner Information
Adagio Therapeutics, Inc.
Adagio Therapeutics, Inc.
Correspondent
James J. Saul Faegre Drinker Biddle & Reath LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
